Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Squamous Cell × Temozolomide × 90 days × Clear all

Sponsor

Conditions

Glioblastoma 48 Glioma 14 Brain Neoplasms 14 Neuroblastoma 10 Sarcoma, Ewing 8 Gliosarcoma 8 Astrocytoma 8 Medulloblastoma 7 Sarcoma 6 Rhabdomyosarcoma 6 Ependymoma 6 Recurrence 5 Osteosarcoma 5 Neoplasms 5 Melanoma 5 Diffuse Intrinsic Pontine Glioma 4 Small Cell Lung Carcinoma 3 Prostatic Neoplasms 3 Oligodendroglioma 3 Neoplasm Metastasis 3 Lymphoma 3 Colorectal Neoplasms 3 Wilms Tumor 2 Somatostatinoma 2 Rhabdoid Tumor 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Neuroectodermal Tumors, Primitive 2 Lymphoma, Follicular 2

Interventions

pembrolizumab 11 Cisplatin 9 Carboplatin 9 Paclitaxel 6 Radiotherapy, Intensity-Modulated 5 Radiotherapy 4 cemiplimab 3 Radiation 3 Docetaxel 3 Blood Specimen Collection 3 alpha-2'-deoxythioguanosine 2 Taxes 2 Standard of Care 2 Nivolumab 2 Drug Therapy 2 toripalimab 1 regorafenib 1 olaparib 1 lenvatinib 1 fludarabine phosphate 1 fludarabine 1 durvalumab 1 bavituximab 1 avelumab 1 atezolizumab 1 aldesleukin 1 aflibercept 1 Vitamin D 1 Vinorelbine 1 Tumor Burden 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡